Patent Assignment
Reel/Frame 050775/0433
Merger and Change of Name
Recorded: 2019-10-21
Pages: 4
Assignors
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Executed: 2018-06-12
ALBERT EINSTEIN COLLEGE OF MEDICINE
Executed: 2018-06-12
Assignee
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVENUE, BRONX, NEW YORK, 10461
Covered Property
(1)
Drug Targeting of Human Indoleamine 2,3-Dioxygenase
Application:
16/432,831 →
Publication:
US 2019/0304569
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 21, 2019
From: YEH, SYUN-RU; LEWIS-BALLESTER, ARIEL; NGOC PHAM, KHOA
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 050775/0220 →
Confirmatory License
Jan 17, 2024
From: ALBERT EINSTEIN COLLEGE OF MEDICINE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066339/0266 →